Publications by authors named "Laith Al-Rabadi"

Collagen IV pathogenic variants are present in Alport syndrome (AS) and some forms of familial focal segmental glomerulosclerosis (FSGS). These conditions pose diagnostic challenges due to overlapping clinical, histological, and genetic features. Ocular coherence tomography (OCT) has emerged as a pivotal diagnostic tool by revealing ocular manifestations characteristic of AS.

View Article and Find Full Text PDF
Article Synopsis
  • Gitelman Syndrome (GS) is a rare genetic disorder that leads to low potassium and magnesium levels, alongside other metabolic issues, and presents unique challenges in managing these conditions during pregnancy.
  • A case study of a 20-year-old woman with GS highlights the use of amiloride, a medication typically used for GS, to successfully manage her persistent low potassium levels during pregnancy and lactation.
  • The treatment with amiloride effectively controlled her symptoms without causing any harmful effects on her newborn, suggesting potential safety for the mother and child under careful management.
View Article and Find Full Text PDF

Here, we used digital spatial profiling (DSP) to describe the glomerular transcriptomic signatures that may characterize the complex molecular mechanisms underlying progressive kidney disease in Alport syndrome, focal segmental glomerulosclerosis, and membranous nephropathy. Our results revealed significant transcriptional heterogeneity among diseased glomeruli, and this analysis showed that histologically similar glomeruli manifested different transcriptional profiles. Using glomerular pathology scores to establish an axis of progression, we identified molecular pathways with progressively decreased expression in response to increasing pathology scores, including signal recognition particle-dependent cotranslational protein targeting to membrane and selenocysteine synthesis pathways.

View Article and Find Full Text PDF

The discovery of new target antigens in membranous nephropathy (MN) has revealed new disease phenotypes and, in some cases, has suggested mechanisms of disease shared by two concurrent autoimmune diseases. Subject of Review: Several recent reports and an accompanying editorial describe the association of anti-contactin-1 (CNTN1) autoantibodies of the IgG4 subclass with a novel subtype of MN that co-occurs with a form of chronic inflammatory demyelinating polyradiculoneuropathy caused by anti-CNTN1 antibodies. CNTN1, the cellular source of which is still undetermined, is identified as the target antigen in the kidney since it is present within glomerular subepithelial deposits and anti-CNTN1 IgG4 antibodies can be eluted from the corresponding kidney biopsy tissue.

View Article and Find Full Text PDF

Pro-inflammatory immune system development, metabolomic defects, and deregulation of autophagy play interconnected roles in driving the pathogenesis of systemic lupus erythematosus (SLE). Lupus nephritis (LN) is a leading cause of morbidity and mortality in SLE. While the causes of SLE have not been clearly delineated, skewing of T and B cell differentiation, activation of antigen-presenting cells, production of antinuclear autoantibodies and pro-inflammatory cytokines are known to contribute to disease development.

View Article and Find Full Text PDF

Genetic testing for pathogenic variants is usually undertaken to investigate the cause of persistent hematuria, especially with a family history of hematuria or kidney function impairment. Alport syndrome experts now advocate genetic testing for persistent hematuria, even when a heterozygous pathogenic or is suspected, and cascade testing of their first-degree family members because of their risk of impaired kidney function. The experts recommend too that or heterozygotes do not act as kidney donors.

View Article and Find Full Text PDF

The identification of the major target antigen phospholipase A2 receptor (PLA2R) in the majority of primary (idiopathic) cases of membranous nephropathy (MN) has been followed by the rapid identification of numerous minor antigens that appear to define phenotypically distinct forms of disease. This article serves to review all the known antigens that have been shown to localize to subepithelial deposits in MN, as well as the distinctive characteristics associated with each subtype of MN. We will also shed light on the novel proteomic approaches that have allowed identification of the most recent antigens.

View Article and Find Full Text PDF
Article Synopsis
  • The EphB2 receptor tyrosine kinase is significantly increased in injured kidney tissues of both mice and humans with chronic kidney disease, indicating a potential role in kidney fibrosis.
  • Mice lacking EphB2 (EphB2KO) showed better kidney function and less injury after ischemia-reperfusion injury, suggesting that EphB2 may be detrimental in this context.
  • Analysis of fibrosis-related genes revealed that many profibrotic gene expressions return to normal levels when EphB2 is absent, highlighting its key role in promoting renal fibrosis after kidney injury.
View Article and Find Full Text PDF

Kidney failure is common in patients with Coronavirus Disease-19 (COVID-19), resulting in increased morbidity and mortality. In an international collaboration, 284 kidney biopsies were evaluated to improve understanding of kidney disease in COVID-19. Diagnoses were compared to five years of 63,575 native biopsies prior to the pandemic and 13,955 allograft biopsies to identify diseases that have increased in patients with COVID-19.

View Article and Find Full Text PDF
Article Synopsis
  • Identification of the novel target antigen HTRA1 explains a subset of primary membranous nephropathy (MN) cases where traditional antigens are not detected, addressing 15%-20% of patients with unknown causes.
  • Utilizing advanced methods such as mass spectrometry and immunoblotting, researchers demonstrated that antibodies to HTRA1 correlated with disease activity, indicating its relevance in MN.
  • The study highlights the significance of HTRA1 in MN, identifying its presence in immune deposits in affected patients and confirming a 4.2% prevalence in a group lacking other known antigens.
View Article and Find Full Text PDF
Article Synopsis
  • The Alport Variant Collaborative's recent meeting expanded the criteria for screening certain gene mutations linked to Alport syndrome, allowing for broader clinical indications like persistent proteinuria and familial kidney issues.
  • They updated the ACMG guidelines for assessing gene variants related to Alport, including identifying specific mutation hotspots in collagen IV chains and noting the limitations of current functional assays.
  • The complexity of Alport syndrome's inheritance patterns prevents establishing a clear threshold for benign variants, and interpreting less severe mutations (hypomorphic variants) in related genes remains difficult, with some variants frequently appearing in normal databases.
View Article and Find Full Text PDF

Introduction: Diabetes is the most common cause of chronic kidney disease (CKD). For patients with diabetes and CKD, the underlying cause of their kidney disease is often assumed to be a consequence of their diabetes. Without histopathological confirmation, however, the underlying cause of their disease is unclear.

View Article and Find Full Text PDF

Immune reconstitution inflammatory syndrome in AIDS patients can lead to an initial worsening of underlying diseases due to body's ability to mount a strong immune response after recovery of CD4 counts.

View Article and Find Full Text PDF
Article Synopsis
  • Acute abdominal pain following the use of Kayexalate and activated charcoal may indicate serious intestinal necrosis.
  • Healthcare providers should be cautious and monitor for this condition when these medications are administered together.
  • To reduce the risk of intestinal necrosis, the simultaneous use of Kayexalate and activated charcoal should be avoided whenever possible.
View Article and Find Full Text PDF

Introduction: Staphylococcal infection-related glomerulonephritis (GN) has been shown to represent a unique form of infection-related GN that contains IgA-dominant deposits and is often seen concurrently with the bacterial infection. Biopsies commonly reveal an endocapillary proliferative and/or exudative or mesangial proliferative GN. Rare cases have been reported to show cryoglobulin-like features, including hyaline pseudothrombi and wireloop deposits; however, detailed characterization of these cases is lacking.

View Article and Find Full Text PDF

Hepatitis C virus (HCV) infection is a common problem in patients treated with maintenance hemodialysis (HD) and is associated with an increased morbidity and mortality and lower quality of life. The major causes of HCV-associated mortality are liver and cardiovascular-related death. HCV-infected HD patients have a higher prevalence of inflammation-related metabolic and vascular diseases, leading to high rates of cardiovascular mortality in patients with end-stage renal disease.

View Article and Find Full Text PDF

There is little information about pregnancy outcomes in patients with active membranous nephropathy (MN), especially those with circulating autoantibodies to M-type phospholipase A₂receptor (PLA₂R), the major autoantigen in primary MN. We present what we believe to be the first known case of successful pregnancy in a 39-year-old woman with PLA₂R-associated MN. In the year prior to pregnancy, the patient developed anasarca, hypoalbuminemia (albumin, 1.

View Article and Find Full Text PDF

Glomerulopathy due to dysproteinemia can have a wide spectrum of pathologic and clinical features based on specific characteristics of the abnormal protein and the response induced within the parenchymal tissue. Monoclonal immunoglobulin G (IgG) deposition can manifest as a different glomerular disease. Proliferative glomerulonephritis (GN) with monoclonal IgG deposits (PGNMID) is a unique entity mimicking immune complex GN that does not conform to any of those subtypes.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with chronic kidney disease (CKD) are at a higher risk for blood clots, especially after certain medical procedures, but effective treatments are limited.
  • Research shows that indoxyl sulfate (IS), a harmful metabolite in CKD, increases a protein called tissue factor (TF) in blood vessel cells by activating the aryl hydrocarbon receptor (AHR).
  • AHR antagonists can lower TF levels and reduce blood clotting risk, suggesting that targeting the IS-AHR pathway could lead to new treatments for managing thrombosis in CKD patients.
View Article and Find Full Text PDF

A patient presented with neuromuscular, respiratory and cardiac symptoms and was initially diagnosed with amyotrophic lateral sclerosis (ALS), myocardial ischaemia and pneumonia. He developed unexplained progressive kidney failure over the ensuing week, and his kidney biopsy showed thrombotic microangiopathy that led to the correct diagnosis of normotensive scleroderma renal crisis. His clinical presentation and course were consistent with systemic sclerosis and normotensive scleroderma renal crisis.

View Article and Find Full Text PDF